MANAGEMENT OF PREGNANT WOMEN WITH DIABETES TREATED WITH INSULIN AT BACH MAI HOSPITAL
Main Article Content
Abstract
Objectives: To investigate the clinical and laboratory characteristics and related factors of pregnant women with insulin-treated diabetes in the third trimester at Bach Mai Hospital, and to evaluate their obstetric management. Subjects: The study included 84 pregnant women with insulin-treated diabetes who delivered at the Department of Obstetrics and Gynecology, Bach Mai Hospital, from June 2023 to June 2024. Results: The mean age of the study subjects was 33.08 ± 5.5 years, with the highest proportion (38.1%) in the 30-35 age group and the lowest (8.3%) in the ≤ 25 age group. 50% of the pregnant women were office workers, and only 8.3% were farmers. 60.7% of the pregnant women were diagnosed with gestational diabetes mellitus (GDM), 28.6% had type 2 diabetes, and only 10.7% were diagnosed with type 1 diabetes. Obstetric history: previous preterm birth, miscarriage, macrosomia, GDM, and preeclampsia/eclampsia were 2.4%, 10.7%, 26.2%, 20.2%, and 13.1%, respectively. The average weight gain was 10.57 ± 5 kg, with the highest percentage (38.1%) in the group gaining >12 kg and the lowest (8.3%) in the group gaining <8 kg. The rate of achieving treatment targets was higher in the pre-gestational diabetes group compared to the GDM group, and the difference was statistically significant (p=0.02). The mean gestational age at delivery was 35.87 ± 2.9 weeks. There was no statistically significant difference between the pre-gestational diabetes and GDM groups regarding the cesarean section rate; pregnancy complications (hypertensive disoders in prenancy, preterm birth, polyhydramnios, stillbirth); APGAR scores at 1 and 5 minutes; and neonatal complications. Conclusion: Maternal complications: There was no statistically significant difference in maternal complications between the pre-gestational diabetes and GDM groups. Neonatal complications: There was no statistically significant difference in the rates of macrosomia, respiratory distress, and neonatal hypoglycemia between the two groups.
Article Details
Keywords
Diabetes Mellitus (DM), Pre-gestational Diabetes Mellitus (PGDM), Gestational Diabetes Mellitus (GDM)
References

2. Phan Thị Thu Hằng. Nghiên cứu đặc điểm lâm sàng, cận lâm sàng và thải độ xử trí đối với thai phụ đái tháo đường thai kỳ điều trị bằng insulin. Trường Đại học Y Hà Nội; 2016.

3. Bùi Sơn Thắng, Đặng Thị Minh Nguyệt. Kết quả xử trí sản khoa của sản phụ đái tháo đường thai kỳ tại bệnh viện sản nhi nghệ an năm 2021-2022. Tạp chí Y học Việt Nam. 2023;522(1)

4. Lê Thị Thanh Tâm. Nghiên cứu phân bố-một số yếu tố liên quan và kết quả sản khoa ở thai phụ đái tháo đường thai kỳ. Trường Đại Học Y Hà Nội; 2015.

5. Vũ Bích Nga. Nghiên cứu glucose máu lúc đói để sàng lọc đái tháo đường thai kỳ và bước đầu đánh giá hiệu quả điều trị. Trường Đại học Y Hà Nội; 2009.

6. Nguyễn Thị Lệ Thu. Nghiên cứu tỷ lệ và cách xử trí trong chuyển dạ đối với thai phụ đái tháo đường thai nghén tại khoa sản bệnh viện bạch mai. Trường Đại học Y Hà Nội; 2010.

7. Yogev và cộng sự. Hyperglycemia and adverse pregnancy outcome (hapo) study: Preeclampsia. Am J Obstet Gynecol. Mar 2010;202(3):255.e1-7. doi:10.1016/j.ajog.2010.01.024


8. Muwafag Hyari và cộng sự. Maternal and fetal outcomes in diabetic pregnant women. JR Med Serv. 2013;20:56-61.
